Valuation of complex license contracts

Abstract

Licensing is an important business model within the drug development industry. Recently license contracts have become extremely complex, including sublicensing, co-development, or profit sharing. Traditional rules of thumb are not sufficient anymore as guidelines in negotiations of deal terms. The authors explain an easy-to-understand model that enables business developers to negotiate financial terms that are fair for both parties.